Corrective Phases R...
Health Care: Drugs
BioDelivery Sciences International Inc. (BDSI: NASDAQ)
$3.17 -0.21 | -6.21%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 3.26M | 3.40M | 62.81M | 263.18K |
| Cost of Sales | 421.12K | -427.14K | 1.17M | -765.78K |
| Gross Operating Profit | 2.84M | 3.83M | 61.65M | 1.03M |
| Selling, General, and Administrative Expenses | 7.69M | 8.00M | 10.32M | 7.30M |
| Research & Development | 20.81M | 10.65M | 10.32M | 10.92M |
| Operating Income before D & A (EBITDA) | -25.65M | -14.81M | 41.00M | -17.20M |
| Depreciation & Amortization | 1.34M | 1.27M | 874.11K | 765.78K |
| Interest Income | 188.70K | 133.61K | 35.60K | 0.00 |
| Other Income - Net | 3.47M | 3.15M | -6.81M | 1.19M |
| Special Income / Charges | 0.00 | -243.65K | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -23.33M | -13.03M | 33.36M | -16.77M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 461.58K |
| Pre-Tax Income | -23.33M | -13.03M | 33.36M | -17.23M |
| Income Taxes | 0.00 | 0.00 | 312.13K | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -23.33M | -13.03M | 33.05M | -17.23M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -23.33M | -13.03M | 33.05M | -17.23M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -23.33M | -13.03M | 33.05M | -17.23M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-23.33M | -12.79M | 33.05M | -17.23M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -23.33M | -13.03M | 33.05M | -17.23M |
| Basic EPS from Continuing Ops. | -0.82 | -0.56 | 1.63 | -0.90 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.82 | -0.56 | 1.63 | -0.90 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.82 | -0.56 | 1.63 | -0.90 |
| Basic Normalized Net Income/Share | -0.82 | -0.55 | 1.63 | -0.90 |
| EPS fr Continuing Ops. | -0.82 | -0.56 | 1.54 | -0.90 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.82 | -0.56 | 1.54 | -0.90 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.82 | -0.56 | 1.54 | -0.90 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.82 | -0.55 | 1.54 | -0.90 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with BDSI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- UserWhole Portfolio
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks Under $5 Outperfo...
- Contributor10 Pharma Stocks With 100% ...
- UserSmall Cap Bargains to follo...
- UserPROS
- UserCloud66 - IRA
Latest BDSI Headlines from TheStreet
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- The Next Big Thing in Biotech: BIO CEO Conference
02.10.12 | 05:02 am - 10 Stocks Under $5 Outperforming in 2012 01.31.12 | 05:01 am
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
- BioDelivery Sciences International Inc. Stock Downgraded (BDSI) 04.01.11 | 06:04 pm
- IPO Watch: 2011 02.16.11 | 01:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Rodman Rambles: Promising Biotechs 09.15.10 | 10:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- Stock Offerings: MGIC Investment 04.20.10 | 11:04 am
Press Releases for BDSI
- BioDelivery Sciences To Present At The Jefferies 2012 Global Healthcare Conference - PR Newswire 05.31.12 | 07:05 am
- BioDelivery Sciences Receives $2.5 Million Milestone From Meda For BREAKYL In E.U. - PR Newswire 05.21.12 | 07:05 am
- BioDelivery Sciences Awarded Patent Resulting In $15 Million Milestone Payment - PR Newswire 04.17.12 | 07:04 am
- BioDelivery Sciences To Present At The Future Leaders In The Biotech Industry Conference - PR Newswire 04.16.12 | 08:04 am
- BioDelivery Sciences To Host Opioid Dependence Investor Event And Webcast On April 11, 2012 - PR Newswire 04.05.12 | 08:04 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Federal Court Grants Request By BioDelivery Sciences For Stay Of MonoSol Litigation - PR Newswire 03.14.12 | 07:03 am
- ONSOLIS Relaunch Postponed Pending Product Modification - PR Newswire 03.12.12 | 07:03 am
- US Patent Office Rejection Of All Claims In Final Asserted MonoSol Patent Further Supports BioDelivery Sciences' Position - PR Newswire 03.06.12 | 09:03 am
- BioDelivery Sciences To Present At Cowen And ROTH Conferences - PR Newswire 03.05.12 | 07:03 am
Partner Headlines for BDSI
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- Legal Developments Bode Well For BioDelivery Sciences - Seeking Alpha 03.15.12 | 08:03 am
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- This Week's Healthcare Stock Watch - Seeking Alpha 09.20.11 | 09:09 am
- Options Brief: BioDelivery Sciences International (BDSI) - Benzinga 12.28.10 | 09:12 am
- BioDelivery Sciences: Signs of Life - Seeking Alpha 09.10.10 | 03:09 pm
- BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug - Fox Business 09.02.10 | 05:09 pm
